Product details
Catalog number BNC682399-100
Price for BNC682399-100
Size / count 1x 100 µL
TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4 Th1 and CD8 Tc1) but not on helper T cells (CD4 Th2 and CD8 Tc2) . In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for TIM3 / HAVCR2 / CD366 (Effector T-Cell Marker) (HAVCR2/192), CF568 conjugate, 0.1mg/mL is BNC682399-100.
TIM3 / HAVCR2 / CD366 (Effector T-Cell Marker) (HAVCR2/192), CF568 conjugate, 0.1mg/mL is available in the following size(s): 1x 100 µL.
TIM3 / HAVCR2 / CD366 (Effector T-Cell Marker) (HAVCR2/192), CF568 conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
TIM3 / HAVCR2 / CD366 (Effector T-Cell Marker) (HAVCR2/192), CF568 conjugate, 0.1mg/mL is manufactured by Biotium.
Estimated delivery time for TIM3 / HAVCR2 / CD366 (Effector T-Cell Marker) (HAVCR2/192), CF568 conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for TIM3 / HAVCR2 / CD366 (Effector T-Cell Marker) (HAVCR2/192), CF568 conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd02b1061270361e109c11/msds/bnc682399-100.pdf.
TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4 Th1 and CD8 Tc1) but not on helper T cells (CD4 Th2 and CD8 Tc2) . In chronic inflammation, autoimmune disorders, and some cancers, TI
Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.
Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.
A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.